ArticlePLoS genetics2026
PARP-2 catalytic activity drives replication-ICL repair in an allele-specific manner during germline development.
Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining genome integrity in the germline is critical for fertility and organismal survival. Here, we identify C. elegans PARP-2 as an essential and non-redundant regulator of replication-coupled DNA repair. PARP-2 localizes to chromatin during germline development and is also present in the nucleolus; replication stress is associated with changes in its nucleolar distribution, linking fork perturbation to nucleolar signaling and ribosomal homeostasis. Loss of PARP-2 leads to embryonic lethality, larval arrest, and hypersensitivity to replication-blocking and crosslinking agents, accompanied by accumulation of recombination intermediates. Strikingly, a catalytic-dead mutant (E509K) causes even more severe defects than the null allele, including hyperactivation of DNA damage pathways and elevated apoptosis, revealing that PARP-2 enzymatic activity not only executes repair but also restrains excessive stress responses. Chromatin profiling further shows enrichment of PARP-2 at promoter-proximal, fragile loci, suggesting a constitutive surveillance role. Together, these findings establish PARP-2 as a multifunctional genome guardian that integrates catalytic and structural roles to maintain genome stability and nucleolar function, with implications for understanding PARP-associated disease mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.